Leadership Overview
Abbott has 10 executives leading key functions including strategy, operational management, financial oversight, and technical compliance.
Focused on advancing global health through medical technology and nutrition, Abbott delivers innovative solutions to improve patient outcomes and address critical needs in chronic disease management and cardiovascular care across diverse international markets.
Focused on advancing global health through medical technology and nutrition, Abbott delivers innovative solutions to improve patient outcomes and address critical needs in chronic disease management and cardiovascular care across diverse international markets.
Leadership Roles at Abbott
Pablo Robles - Chief Executive Officer
Pablo Robles, the Chief Executive Officer at Abbott, directs the overarching strategic vision for this global healthcare enterprise. Overseeing the development of medical technologies, diagnostics, and nutrition products, the Chief Executive Officer ensures alignment with the core mission of improving health outcomes. Pablo Robles manages high-level interactions with the Board to drive long-term growth and market expansion. By prioritizing innovation in chronic disease management and cardiovascular care, the Chief Executive Officer maintains a competitive edge in the pharmaceutical and medical device sectors. This leadership role involves navigating complex regulatory environments while scaling operations across North American and international markets. Through rigorous focus on operational efficiency and product excellence, the Chief Executive Officer secures the company's position as a leader in life-enhancing healthcare solutions. Strategic decisions made by the Chief Executive Officer directly influence the trajectory of global health initiatives.
Priti Hota - Regional Chief Financial Officer
Priti Hota, the Regional Chief Financial Officer at Abbott, manages financial planning and fiscal performance within specific geographic territories. Overseeing regional budget allocations and revenue forecasting, the Regional Chief Financial Officer ensures that financial strategies support the delivery of medical technologies and nutrition products. Priti Hota analyzes market trends to optimize resource distribution and maximize profitability across the assigned region. By aligning financial goals with local healthcare demands, the Regional Chief Financial Officer facilitates sustainable growth and operational stability. This role involves coordinating with global finance teams to maintain consistent reporting standards while addressing regional economic nuances. Through disciplined fiscal oversight, the Regional Chief Financial Officer enables the company to expand its footprint in critical medical markets. Hota drives financial performance by identifying cost-saving opportunities and investment areas that enhance the overall impact of the company's diagnostic and pharmaceutical offerings in the region.
Phil Boudreau - Executive VP, Finance & Chief Financial Officer
Phil Boudreau, the Executive VP, Finance & Chief Financial Officer at Abbott, directs the global financial strategy and capital allocation for the entire organization. Overseeing financial reporting, treasury operations, and investor relations, the Executive VP, Finance & Chief Financial Officer ensures the fiscal health of the company. Phil Boudreau manages the balance sheet to support long-term investments in medical technology and diagnostic innovation. By providing strategic financial guidance to the Board, the Executive VP, Finance & Chief Financial Officer enables the pursuit of high-growth opportunities in chronic disease management. This leadership role involves maintaining rigorous internal controls and ensuring transparency in all financial disclosures. Through comprehensive financial planning, the Executive VP, Finance & Chief Financial Officer supports the company's mission to deliver life-changing health solutions. Boudreau drives value creation by optimizing the capital structure and ensuring that financial resources align with the strategic objectives of the global healthcare business.

Tabish Aseem - Director, Finance & Chief Financial Officer
Tabish Aseem, the Director, Finance & Chief Financial Officer at Abbott, oversees financial operations for specific business units, focusing on profitability and cost management. Managing the financial health of key product lines, the Director, Finance & Chief Financial Officer ensures that resources are allocated to maximize the impact of medical technologies. Tabish Aseem analyzes operational data to identify efficiencies and drive margin improvements across the portfolio. By providing financial insights to department heads, the Director, Finance & Chief Financial Officer supports informed decision-making regarding product development and market entry. This role involves maintaining strict financial discipline while fostering innovation in diagnostics and nutrition. Through detailed financial modeling and performance tracking, the Director, Finance & Chief Financial Officer enables the company to sustain its competitive advantage. Aseem drives financial accountability, ensuring that every business unit contributes effectively to the overall growth and mission of the organization in the global healthcare market.
Maithilee Mistry - Group Chief Financial Officer (India)
Maithilee Mistry, the Group Chief Financial Officer (India) at Abbott, manages the financial strategy and fiscal operations within the Indian market. Overseeing local revenue streams and regulatory compliance, the Group Chief Financial Officer (India) ensures that the company's medical and nutrition products reach patients efficiently. Maithilee Mistry analyzes local market dynamics to tailor financial strategies that support growth in this key region. By coordinating with global finance teams, the Group Chief Financial Officer (India) maintains alignment with corporate standards while addressing the specific economic needs of the Indian healthcare sector. This role involves managing local investments and ensuring that financial resources are directed toward high-impact medical solutions. Through strategic fiscal management, the Group Chief Financial Officer (India) enables the company to strengthen its presence and improve health outcomes in the region. Mistry drives financial performance by optimizing local operations and ensuring that the company remains a trusted provider of healthcare solutions.
Michelle Wakeley - Chief of Staff
Michelle Wakeley, the Chief of Staff at Abbott, coordinates executive workflows and facilitates cross-functional collaboration across the organization. Managing the daily operations of the leadership office, the Chief of Staff ensures that strategic priorities receive immediate attention and resources. Michelle Wakeley synthesizes complex data from various departments to support informed decision-making at the highest levels. By streamlining communication between the C-suite and operational teams, the Chief of Staff optimizes internal processes and enhances organizational agility. This role involves overseeing high-priority projects that span medical technology and diagnostic divisions, ensuring that every initiative aligns with the broader corporate mission. Through meticulous planning and execution, the Chief of Staff drives the implementation of key business strategies. Wakeley maintains a focus on operational excellence, ensuring that the company remains responsive to evolving healthcare needs while supporting the seamless integration of new medical solutions into global markets.
Cory Adams - Cybersecurity & Compliance Chief of Staff
Cory Adams, the Cybersecurity & Compliance Chief of Staff at Abbott, architects robust digital defense frameworks to protect sensitive medical data and proprietary research. Overseeing the integration of security protocols across diagnostic and pharmaceutical platforms, the Cybersecurity & Compliance Chief of Staff ensures strict adherence to global regulatory standards. Cory Adams manages the intersection of technology and compliance, mitigating risks associated with digital healthcare infrastructure. By implementing advanced threat detection systems, the Cybersecurity & Compliance Chief of Staff safeguards the integrity of medical technology operations. This leadership role involves collaborating with IT and legal teams to maintain a secure environment for patient data and corporate assets. Through proactive risk management, the Cybersecurity & Compliance Chief of Staff supports the company's commitment to trust and reliability in the healthcare industry. Adams drives the adoption of secure practices, ensuring that innovation in medical diagnostics remains protected against emerging cyber threats.
Mayur Joshi - Chief of Staff, MD's Office
Mayur Joshi, the Chief of Staff, MD's Office at Abbott, facilitates the operational activities of the medical directorate to ensure clinical excellence. Overseeing the integration of medical research into product development, the Chief of Staff, MD's Office ensures that all innovations meet the highest standards of patient care. Mayur Joshi coordinates between clinical teams and executive leadership to align medical strategy with business goals. By managing the flow of clinical data and research findings, the Chief of Staff, MD's Office supports the development of advanced diagnostics and medical devices. This role involves overseeing the implementation of clinical trials and ensuring that medical needs drive the innovation pipeline. Through effective coordination, the Chief of Staff, MD's Office enables the company to address complex health challenges with evidence-based solutions. Joshi drives the alignment of medical expertise with corporate strategy, ensuring that every product contributes to the company's mission of improving health outcomes.
Steven Guion - Director, Financial Technical Operations & Chief of Staff
Steven Guion, the Director, Financial Technical Operations & Chief of Staff at Abbott, bridges the gap between financial systems and technical operational requirements. Overseeing the implementation of advanced financial software and data analytics, the Director, Financial Technical Operations & Chief of Staff ensures that the company leverages technology to optimize fiscal performance. Steven Guion manages the integration of technical workflows with financial reporting to enhance accuracy and speed. By streamlining operational processes, the Director, Financial Technical Operations & Chief of Staff supports the company's ability to scale its medical technology and diagnostic services. This role involves coordinating with IT and finance teams to ensure that technical infrastructure supports strategic financial goals. Through the application of data-driven insights, the Director, Financial Technical Operations & Chief of Staff enables more precise resource management. Guion drives operational efficiency, ensuring that the company's financial systems remain robust and capable of supporting complex global healthcare operations.
Marcelo Palley - Senior Director - Chief of Staff, PMO and Operational Excellence
Marcelo Palley, the Senior Director - Chief of Staff, PMO and Operational Excellence at Abbott, leads the project management office to drive continuous improvement across all business functions. Overseeing the execution of strategic initiatives, the Senior Director - Chief of Staff, PMO and Operational Excellence ensures that projects are delivered on time and within scope. Marcelo Palley implements lean methodologies to enhance operational efficiency in the development of medical technologies and diagnostics. By fostering a culture of excellence, the Senior Director - Chief of Staff, PMO and Operational Excellence supports the company's mission to deliver high-quality healthcare solutions. This role involves coordinating cross-functional teams to resolve bottlenecks and optimize workflows. Through rigorous project oversight, the Senior Director - Chief of Staff, PMO and Operational Excellence enables the company to remain agile and responsive to market demands. Palley drives operational success, ensuring that every initiative contributes to the company's long-term growth and commitment to patient health.
Explore Leadership Teams in Manufacturing
Founded in 1958 and headquartered in Chatswood, Australia, iNova Pharmaceuticals is an international organization that develops, markets, and sells a wide-range of prescription medicines and non-prescription consumer health products across Asia, Australia and New Zealand, and Africa.
Company Leadership DS
PS
SE
AJ
Sarepta Therapeutics, Inc. is a global commercial-stage biopharmaceutical company founded in 1980 and headquartered in Cambridge, Massachusetts. The company is focused on the discovery, development, and commercialization of precision genetic medicines for rare diseases, with particular leadership in Duchenne muscular dystrophy and limb-girdle muscular dystrophies. Sarepta's multi-platform Precision Genetic Medicine Engine spans gene therapy, RNA-targeted therapeutics, and gene editing modalities. The company holds multiple FDA-approved treatments and maintains a broad pipeline of programs across neuromuscular and central nervous system disorders. Sarepta operates globally with locations across North America, Europe, and Asia, and trades on the NASDAQ under the ticker symbol SRPT.
Company Leadership
AN

ZG
RemeGen is a biopharmaceutical company focused on developing innovative drugs for autoimmune diseases and cancers. Their flagship products include Telitacicept, a dual-target fusion protein for autoimmune conditions, and Disitamab Vedotin, an antibody-drug conjugate for cancer treatment. The company has a robust product pipeline with numerous drugs in various stages of research and development. RemeGen aims to serve patients globally, leveraging its advanced technology and strong scientific support.
Company Leadership JF
JL
ST
MS
Alkermes is a global biopharmaceutical enterprise that specialises in developing and commercialising innovative medicines for people living with complex psychiatric and neurological disorders. Headquartered in Dublin, Ireland, the company combines deep neuroscience expertise with patient‑inspired science to pursue treatments for conditions such as addiction, schizophrenia, bipolar disorder, opioid dependence and other central nervous system diseases. Its approach integrates scientific research, clinical development and specialised commercial infrastructure to deliver both marketed medicines and investigational candidates, aiming to address serious unmet medical needs and improve how chronic neurological and mental health conditions are managed.
Company Leadership


SS